RxDoctor Payments DataLook up a doctor →

Kristina Nikolakeas, DO

Family Medicine · Burton, MINPI 1336342799

Payments from drug & device makers

$25,276in general payments, 2019–2025

Across 1,591 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Amgen$2K
  • Novo Nordisk$1K
  • Harmony Biosciences LLC$1K
  • Lilly USA, LLC$1K
  • plus $15K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)76$2,243
AbbVie(2 entities)227$2,205
Amgen(2 entities)164$2,076
Novo Nordisk102$1,318
Harmony Biosciences LLC61$1,243
Lilly USA, LLC87$1,079
Pfizer75$989
Boehringer Ingelheim59$969
Teva Pharmaceuticals USA, Inc.44$932
GSK50$916
Corcept Therapeutics33$727
Biohaven Pharmaceuticals, Inc.12$607
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC40$600
Lundbeck LLC38$566
Otsuka America Pharmaceutical, Inc.29$518
Vanda Pharmaceuticals Inc.28$474
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)37$461
Novartis27$429
Ironwood Pharmaceuticals, Inc18$396
Bayer29$387
Astellas Pharma US Inc18$370
Alkermes, Inc.13$352
Takeda Pharmaceuticals U.S.A., Inc.16$295
Paratek Pharmaceuticals, Inc.25$263
Exact Sciences12$260
Sentynl Therapeutics, Inc.26$256
Johnson & Johnson15$248
Collegium Pharmaceutical, Inc.14$243
Axsome Therapeutics, Inc.12$232
Neurocrine Biosciences, Inc.12$216
Radius Health, Inc.9$207
Supernus Pharmaceuticals, Inc.13$196
Sanofi-aventis U.S. LLC11$196
Merck15$185
Xeris Pharmaceuticals, Inc.9$172
Sunovion Pharmaceuticals Inc.10$171
Nestle Healthcare Nutrition Inc.10$158
Biohaven Pharmaceutical Holding Company Ltd.7$146
Abbott7$125
Eisai Inc.5$120
Lexicon Pharmaceuticals, Inc.1$117
Medtronic(2 entities)8$107
Indivior Inc.4$105
Scilex Pharmaceuticals Inc.5$99
Idorsia Pharmaceuticals US Inc5$92
Ironshore Pharmaceuticals Inc.5$86
Dexcom, Inc.5$83
Zyla Life Sciences, Inc.6$79
Ossur Americas, Inc.3$72
Jazz Pharmaceuticals Inc.3$65
Intra-sana Laboratories3$65
Phathom Pharmaceuticals, Inc.4$64
Aimmune Therapeutics, Inc.3$58
IBSA Pharma Inc.4$56
Daiichi Sankyo Inc.3$54
Insulet Corporation3$54
Verona Pharma, Inc.3$43
Mylan Specialty L.p.2$40
Sanofi Pasteur Inc.2$34
Orexo US, Inc.2$32

How this compares

$25,276 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Medicare billing

Part B allowed, 2024
$77,260
Medicare patients
168
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Burton

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →